NEJM reports that DTC spend increased 330% between '96-'05

Share this article:
In a critical Aug. 16 article on the impact of DTC advertising, The New England Journal of Medicine reported that spending on DTC pharmaceutical advertising increased by 330% between 1996 and 2005, while the number of warning and untitled letters issued on ads fell from 142 in 1997 to 21 in 2006.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters